arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

CENTENE CORP

CNC
$65.77 ▲ +1.58 (+2.45%) at close
Healthcare ·Hospital & Medical Service Plans ·USHospital & Medical Service Plans
72 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
24
Health
Poor
Bearish
auto_awesome

Analytical Summary

CENTENE CORP faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $32.5B
Dividend Yield
Revenue Growth 9.9%
Op. Margin 2.2%
ROIC 2.3%
FCF / Share $6.92
Trailing P/E 29.8x
Price / Book 1.4x
FCF Yield 10.5%
Debt / Equity 0.71
info Valuation on last close. End-of-day price, Aug 7, 2026.

72-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$53.58B
↑ +9.9%
Net Income Profit after all expenses
$1.09B
↓ -29.2%
Operating Margin Operating profit as % of sales
2.2%
↓ -40.0% 21th
FCF / Share Free cash flow per share
$6.92
↓ -18.3%
Long-Term Debt Long-term obligations
$16.03B
↓ -1.7%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
26
Returns
22
Financial Health
31
Cash Quality
12

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 72 quarters